Lofexidine appears as good as diazepam in combating symptoms of opioid withdrawal and has better treatment retention rate than diazepam, suggesting lofexidine as a viable alternative when standard opioid-assisted therapies are unavailable, a recent study shows.
There appears to be a connection between obsessive-compulsive disorder (OCD) and geographical latitude, suggesting that exposure to sunlight may be an important mediating factor in the disorder, a recent study has found.
Patients with first-episode psychosis (FEP) may benefit from continuing their antipsychotic treatment, with a recent study showing that treatment maintenance protects against relapse risk, whereas discontinuation for ≥2 months increases the risk.
Treatment with a computer-based cognitive-behavioural therapy (CBT4CBT) as a virtual standalone intervention in a clinical setting to a diverse sample of patients with current substance use disorders is safe, effective and durable compared to standard treatment strategies, according to a recent study. In addition, CBT4CBT is well-liked by the participants.
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.